Medical Devices Startups

Biosens8 develops wearable health monitoring devices that track physiological markers including cortisol and women's health metrics. The company serves health-conscious consumers interested in personal biometric monitoring.

1 investor

Biosense Technologies designs portable and affordable diagnostic devices for basic healthcare screening, leveraging digital technology to address gaps in access to diagnostic services across India's healthcare system.

1 investor

BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.

1 investor

Biosurfit develops point-of-care diagnostic instruments and tests for blood analysis, including devices for measuring C-reactive protein, blood counts, and HbA1c levels. The company serves hospitals, clinics, and mobile health units across Europe, and has expanded into contract manufacturing services for diagnostic and medical device companies.

1 investor

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

1 investor

BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain. The company's offerings have anti-inflammation and anti-scarring properties and are used by surgeons and healthcare professionals to help patients heal faster.

1 investor

1 investor

Biotree develops metabolomics and proteomics analysis platforms and services for research institutions and pharmaceutical companies, offering laboratory testing solutions, medical devices, and cloud-based lab information systems.

1 investor

Biotronics3D provides 3Dnet, a cloud-native medical imaging platform that integrates PACS, RIS, patient portals, and advanced diagnostic visualization tools for healthcare organizations. The solution supports multi-site deployments with AI-driven workflows and enables secure collaboration among healthcare providers and patients.

1 investor

The company develops diagnostics and diagnostic solutions for laboratory technicians, physicians, and patients, prioritizing fast and reliable testing capabilities.

1 investor

BioVentrix is a medical device company that develops less invasive therapies to treat heart failure by reconstructing the dilated left ventricle using myocardial micro-anchor implants. The company serves cardiothoracic surgeons and patients with ischemic heart failure.

1 investor

Biovox works with PLA (polylactic acid), a biobased polymer, and evaluates its use as a material for drug delivery devices such as autoinjectors. The company focuses on sustainable material solutions for medical/pharmaceutical device applications.

1 investor

BIOW develops solutions targeting the health effects of air pollution exposure, specifically investigating how bioavailable anions may support mitochondrial function and neural resilience in the context of neurodegenerative diseases and aging. The company conducts clinical research on biomarker changes and microbiome effects through advanced proteomics and metabolomics analysis.

1 investor

BioWave develops patented high-frequency neurostimulation devices that deliver therapeutic stimulation deep into the body to block pain signals at the nerve source, aimed at chronic pain patients and athletes. Its products are used in settings such as Veterans Affairs, orthopedic and pain health systems, and by professional sports trainers.

1 investor

BioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

1 investor

Bioxis develops proprietary biomaterials based on chitosan and hyaluronic acid for aesthetic dermatology applications. The company creates tissue induction products designed to regenerate tissue and collagen with long-lasting effects.

1 investor

Birth Model uses machine learning and patient data to predict delivery times and optimize labor and delivery operations in hospitals. The platform helps manage staffing, reduce patient wait times, and improve operational efficiency for obstetric care providers.

1 investor

B_Platform is a genomic analysis software that uses AI and big data to prioritize genetic variants and organize sequencing results for clinical interpretation. It supports multiple sequencing platforms and associates variants with patient phenotypes for healthcare professionals and clinical laboratories.

1 investor

BiVACOR is a clinical-stage medical device company developing a Total Artificial Heart (TAH), an electro-mechanical rotary blood pump with a single magnetically levitated rotor that replaces both ventricles for patients with end-stage biventricular heart failure. The device is undergoing an FDA-approved first-in-human Early Feasibility Study as a bridge-to-transplant solution.

1 investor

Blacksmith Medicines discovers and develops small molecule inhibitors of metal-dependent enzymes for oncology and infectious disease applications. The company uses chemistry-based drug discovery approaches to address unmet medical needs.

1 investor

A biotech company focused on hemostasis and RNA therapeutics, with expertise across translational science, manufacturing, and commercialization.

1 investor

Bleps Vision makes TOCO, a portable corneal topographer used for check-ups and documentation of corneal conditions such as keratoconus, and for contact lens fitting. It targets eye-care and vision-health professionals.

1 investor

BliNK Biomedical develops treatments and therapeutics in the biopharmaceutical industry. The company is led by executives with extensive backgrounds in drug discovery, pharmaceutical development, and biotech commercialization.

1 investor

Bloomer Tech develops digital biomarkers and precision cardiovascular care built around female physiology. It offers cardiovascular monitoring and data services focused on women's health, using an investigational device.

1 investor